cryptorchidism: The failure of one or both testes of a male fetus to descend from the abdomen into the scrotum during the late part of pregnancy. If not surgically corrected in early childhood, males may be at increased risk for testicular cancer later in life.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
436 |
4. Check minimum number of eventsNone |
436 |
5. Include endpointsNone |
436 |
6. Filter based on genotype QC (FinnGen only) |
371 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_GENITAL_ORGANS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- Q5
- Name in latin
- Retentio testis
Similar endpoints
↥List of similar endpoints to
Undescended testicle
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of genital organs
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 371 | - | 371 |
| Unadjusted period prevalence (%) | 0.17 | - | 0.17 |
| Median age at first event (years) | 7.32 | - | 7.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 404
- Matched controls
- 4024
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
+∞
307.7
325
*
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
+∞
216.5
188
*
KFH10
NOMESCO Finland
Orchiopexy
55.8
151.4
88
20
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
+∞
84.3
78
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
22.1
64.1
49
25
Q55.20
ICD-10 Finland
Retractile testis
123.8
51.1
54
5
Q53.9
ICD-10 Finland
Undescended testicle, unspecified
+∞
45.6
43
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.5
39.3
71
127
JAH01
NOMESCO Finland
Laparoscopy
11.4
28.0
30
28
G03GA01
ATC
chorionic gonadotrophin; parenteral
66.6
27.3
31
5
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
24.1
189
937
ZXE00
NOMESCO Finland
One hour or less
2.7
21.5
196
1034
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
19.2
154
754
H01AC01
ATC
somatropin; parenteral
5.5
18.9
38
74
7525A
ICD-9 Finland
Congenital anomalies of genital organs, Undescended testicle[RETENTIO TESTIS (CRYPTORCHISMUS)]
21.2
17.9
26
13
Q53.0
ICD-10 Finland
Ectopic testis
+∞
17.8
17
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.8
17.6
42
95
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.8
16.6
39
87
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.8
16.6
55
160
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
16.0
150
778
ZXA00
NOMESCO Finland
Right side
2.8
15.8
93
384
ZXA05
NOMESCO Finland
Left side
2.9
15.8
89
359
101
Kela drug reimbursment
Anterior pituitary hypofunction
5.9
15.2
28
50
121
Kela drug reimbursment
Severe hypofunction of sexual glands
26.7
13.4
18
7
7505
FHL
Funicular lysis and orchidopexy
17.4
13.1
20
12
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
13.0
101
475
E29.1
ICD-10 Finland
Testicular hypofunction
13.0
11.7
20
16
R62.0
ICD-10 Finland
Delayed milestone
3.4
11.5
43
135
N50.0
ICD-10 Finland
Atrophy of testis
+∞
11.5
11
*
F83
ICD-10 Finland
Mixed specific developmental disorders
3.5
10.9
39
119
ZXA10
NOMESCO Finland
Bilateral
2.4
10.7
85
401
Q53
ICD-10 Finland
Undescended testicle
+∞
10.4
10
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.5
10.4
26
61
602
Kela drug reimbursment
Children's severe malnutrition
4.0
10.1
29
76
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
9.7
105
563
ZXD20
NOMESCO Finland
Day surgery
2.7
9.0
52
210
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
4.8
8.9
20
43
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
20.5
8.5
12
6
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.5
8.2
20
46
75210
ICD-8 Finland
Congenital anomalies of genital organs, Undescended testicle
15.3
7.7
12
8
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
7.5
50
216
FM2CE, ,
NOMESCO Finland
2.7
7.5
40
155
Z31.5
ICD-10 Finland
Genetic counselling
2.6
7.3
43
175
Q54.2
ICD-10 Finland
Hypospadias, penoscrotal
+∞
7.3
7
*
Q55.1
ICD-10 Finland
Hypoplasia of testis and scrotum
+∞
7.3
7
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
7.2
38
146
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
7.1
59
282
UKC02
NOMESCO Finland
Cystoscopy
2.6
7.1
42
172
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
14.0
6.9
11
8
XKD00
NOMESCO Finland
Uroflowmetry
2.3
6.8
52
239
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
17.0
6.8
10
6
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
22.9
6.7
9
*
301
Kela drug reimbursment
Growth hormone
6.0
6.7
17
29
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
6.6
297
2426
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
6.5
79
438
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
+∞
6.3
6
*
Q55.00
ICD-10 Finland
Congenital Monorkism
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
53
161
3.62
14.99
3.1
2.3
12.78
6.34
iu/l
1.46
32
91
62
214
3.23
14.35
3.0
2.2
9.04
4.19
u/l
2.34
37
134
9
6
15.23
5.91
1.9
1.2
13.28
36.44
ug/l
—
9
6
18
55
3.37
5.05
6.2
6.0
1.98
2.07
ug/l
0.05
18
55
47
238
2.09
4.88
5.5
11.8
93.79
90.52
%
0.44
47
238
49
266
1.95
4.22
10.3
8.4
66.45
64.48
ng/l
0.09
44
258
85
553
1.67
4.03
4.8
5.8
1367.41
1659.71
ng/l
0.23
77
457
259
2200
1.48
3.47
3.4
3.5
5.74
5.72
mmol/l
0.05
240
2041
249
2104
1.47
3.39
4.0
3.2
14.92
14.85
pmol/l
0.16
233
1923
256
2198
1.44
3.04
5.2
4.8
36.70
37.84
mmol/mol
1.22
240
2111
183
1480
1.42
3.04
5.8
3.6
12.83
255.78
e6/l
—
6
23
132
1017
1.43
2.82
3.4
3.5
—
—
estimate
—
0
0
91
654
1.50
2.78
9.3
10.4
2.02
1.06
mmol/l
2.58
76
538
76
526
1.54
2.76
4.3
6.8
29.99
30.70
s
0.73
76
519
76
527
1.54
2.74
3.4
4.4
1.44
1.77
mg/l
0.38
52
383
284
2510
1.43
2.70
4.4
3.8
1.97
2.00
mu/l
0.18
268
2338
153
1223
1.40
2.63
4.9
3.7
71.05
68.44
nmol/l
0.56
146
1159
90
653
1.48
2.61
3.6
3.5
—
—
—
0
0
20
96
2.13
2.45
1.4
1.9
—
—
—
0
0
124
978
1.38
2.25
2.0
2.0
1.35
1.36
mmol/l
0.08
116
882
321
2940
1.43
2.19
20.5
16.6
139.69
139.61
mmol/l
0.27
312
2880
18
87
2.11
2.18
1.5
1.9
—
—
—
0
0
321
2944
1.42
2.13
20.6
16.7
3.99
3.99
mmol/l
0.03
311
2870
22
116
1.94
2.13
2.0
1.6
312.18
315.73
mu/l
0.02
22
111
62
439
1.48
2.03
4.3
3.1
19.53
22.87
%
1.63
62
429
275
2476
1.33
1.94
4.1
3.9
4.36
4.39
mmol/l
0.22
265
2371
13
59
2.23
1.84
5.3
5.0
22.31
23.24
umol/l
0.18
13
59
6
17
3.55
1.83
1.3
2.7
129.67
1328.53
mg
—
6
17
20
108
1.89
1.83
1.5
1.9
—
—
—
0
0
14
66
2.15
1.82
3.2
5.3
99.21
99.15
%
0.00
14
66
23
132
1.78
1.75
1.7
1.8
22.35
33.13
ng/l
0.55
23
132
273
2475
1.30
1.72
4.4
4.1
2.71
2.70
mmol/l
0.06
260
2354
344
3229
1.41
1.69
16.7
14.8
71.92
73.01
umol/l
0.31
337
3186
195
1697
1.28
1.68
9.5
8.6
6.27
6.42
mmol/l
0.45
187
1644
56
405
1.44
1.66
11.3
12.0
105.02
104.59
mmol/l
0.23
56
405
135
1125
1.29
1.62
9.4
8.4
38.72
37.52
g/l
1.97
126
1076
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
26
2.71
1.58
1.6
1.7
87.43
126.62
%
—
7
26
98
790
1.31
1.50
2.3
1.8
99.75
98.02
pmol/l
0.15
54
396
17
94
1.84
1.48
1.3
1.4
386.55
347.15
ug/g
0.36
11
55
97
783
1.31
1.47
3.8
3.6
2.39
2.38
mmol/l
0.36
92
725
6
22
2.74
1.43
1.5
1.2
124.50
111.77
pmol/l
—
6
22
6
22
2.74
1.43
3.0
3.3
1.21
1.19
mmol/l
—
6
22
6
22
2.74
1.43
3.0
3.3
106.00
105.77
mmol/l
—
6
22
268
2452
1.26
1.42
4.1
3.8
1.28
1.29
mmol/l
0.23
258
2333
15
81
1.88
1.40
3.3
3.2
1.02
1.02
ratio
0.34
15
75
73
571
1.33
1.38
4.4
4.0
25.24
22.26
%
0.47
32
225
93
756
1.29
1.34
4.8
4.5
1.76
1.75
ug/l
0.01
84
674
11
54
2.06
1.32
7.6
5.3
9.64
8.33
%
0.35
11
54
11
54
2.06
1.32
3.8
2.6
37.55
42.81
%
0.41
11
54
220
1980
1.23
1.30
8.2
7.8
123.94
112.68
u/l
0.92
210
1901
6
24
2.51
1.30
1.3
1.6
105.17
129.92
%
—
6
24
31
211
1.50
1.27
3.6
11.9
126.10
131.57
g/l
0.68
31
204
11
55
2.02
1.27
1.3
1.4
—
—
—
0
0
250
2288
1.23
1.23
3.8
3.4
1.21
1.24
mmol/l
0.29
239
2170
23
148
1.58
1.21
1.9
2.1
—
—
—
0
0
56
430
1.34
1.20
3.2
2.8
0.61
0.76
ug/l
0.97
32
230
23
149
1.57
1.18
1.9
2.1
—
—
—
0
0
21
135
1.58
1.12
1.4
1.4
—
—
—
0
0
8
40
2.01
1.12
1.3
1.1
33.84
37.81
iu/ml
—
8
40
151
1326
1.21
1.09
4.8
3.6
0.00
0.02
estimate
0.50
23
214
20
128
1.59
1.09
4.3
7.0
25.63
24.50
mmol/l
0.66
20
120
377
3644
1.46
1.09
23.9
20.0
248.89
253.55
e9/l
0.70
363
3522
5
21
2.39
1.09
9.4
9.2
—
—
—
0
0
377
3645
1.45
1.07
23.8
19.9
87.48
87.26
fl
0.33
372
3611
21
137
1.56
1.06
4.1
7.6
57.74
57.01
%
0.05
21
130
30
212
1.44
1.05
2.2
1.8
—
—
—
0
0
63
503
1.29
1.05
4.5
4.3
360.94
970.93
ng/l
1.44
51
342
377
3647
1.44
1.05
23.9
19.9
4.80
4.80
e12/l
0.02
363
3518
377
3647
1.44
1.05
25.4
21.1
41.40
42.85
%
0.59
372
3611
121
1043
1.22
1.05
3.9
4.8
34.33
38.14
u/l
0.75
115
995
377
3648
1.44
1.03
24.3
20.3
141.66
141.09
g/l
0.27
372
3615
9
157
0.56
1.00
1.7
1.9
—
—
—
0
0
29
206
1.43
1.00
2.0
1.7
—
—
—
0
0
24
164
1.49
1.00
18.8
19.3
16.88
16.15
%
0.54
24
158
334
3183
1.26
0.99
11.4
10.9
32.36
31.96
u/l
0.09
322
3104
15
92
1.65
0.97
1.7
1.3
—
—
—
0
0
9
52
1.74
0.92
11.2
7.1
6.59
7.97
pmol/l
—
9
52
13
78
1.68
0.91
1.0
1.0
1.46
1.38
g/l
0.29
13
70
148
1317
1.19
0.90
4.8
3.6
0.00
5.44
estimate
0.50
24
226
168
1513
1.18
0.89
18.4
12.5
1.21
1.22
mmol/l
0.30
155
1382
147
1310
1.19
0.88
4.8
3.5
0.00
0.00
estimate
-0.00
24
237
24
169
1.44
0.88
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
87
1.62
0.87
9.0
22.3
0.35
0.31
iu/ml
—
8
52
27
195
1.41
0.87
2.1
3.8
30.32
30.07
%
0.05
19
138
6
30
2.01
0.87
12.2
12.3
—
505.67
—
0
6
6
30
2.01
0.87
4.3
4.2
712.50
884.73
u/ml
—
6
30
38
292
1.33
0.85
15.3
14.7
15.70
13.74
kpa
1.05
38
282
22
154
1.45
0.84
2.2
3.6
65.33
77.72
ml/min/173m2
—
6
54
66
549
1.24
0.81
4.5
4.7
5.80
37.95
mg/mmol
0.62
51
408
32
245
1.33
0.75
15.2
14.2
124.81
127.15
g/l
0.22
32
239
25
184
1.38
0.74
3.2
10.9
0.64
0.58
%
0.48
25
184
5
26
1.93
0.70
1.2
1.2
234.80
187.10
iu/ml
—
5
26
112
998
1.16
0.66
4.3
4.4
8.46
8.92
mmol/l
0.37
104
917
71
609
1.20
0.66
20.4
9.4
1.45
0.95
mmol/l
0.99
58
442
61
516
1.21
0.65
1.7
1.5
19.40
18.91
nmol/l
0.10
53
441
5
29
1.73
0.63
1.0
1.1
—
—
—
0
0
5
29
1.73
0.63
1.2
1.6
—
—
—
0
0
5
29
1.73
0.63
9.2
7.1
—
—
—
0
0
5
29
1.73
0.63
1.0
1.4
—
—
—
0
0
37
297
1.27
0.63
1.9
2.6
40.37
36.45
u/l
0.11
27
257
6
103
0.57
0.63
1.0
1.1
—
—
—
0
0
6
104
0.57
0.62
1.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
5.85
—
0
18
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
155
1426
1.13
0.58
21.1
13.5
1.22
1.22
mmol/l
0.40
147
1355
6
35
1.72
0.58
1.2
1.4
—
—
—
0
0
8
54
1.49
0.57
1.6
1.8
—
—
—
0
0
14
194
0.71
0.57
1.1
1.2
—
30.82
—
0
6
6
36
1.67
0.56
2.7
1.6
—
—
—
0
0
8
125
0.63
0.55
8.4
10.5
26.63
24.01
mmol/l
—
8
118
234
2213
1.13
0.55
13.0
11.2
99.72
98.75
ml/min/173m2
0.21
199
1849
9
61
1.48
0.54
2.1
2.0
—
—
—
0
0
101
911
1.14
0.51
4.2
3.1
0.05
0.01
estimate
0.29
21
209
102
922
1.14
0.50
8.1
4.1
0.28
0.26
e6/l
0.03
81
666
7
45
1.56
0.49
2.0
1.9
0.00
0.00
g/l
—
7
40
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
13
93
1.41
0.48
5.7
4.1
—
—
—
0
0
69
609
1.15
0.47
6.4
3.7
0.37
0.39
e6/l
0.04
47
321
7
47
1.49
0.47
1.1
1.3
222.71
250.70
pmol/l
—
7
41
22
275
0.79
0.47
1.2
1.2
3.52
2.85
u/ml
0.08
13
214
39
328
1.20
0.47
2.5
2.7
2.42
2.44
mmol/l
0.55
33
282
146
1355
1.11
0.46
8.2
8.4
19.44
21.37
umol/l
0.26
135
1294
11
77
1.43
0.45
1.1
1.1
—
20.91
—
0
11
11
78
1.42
0.42
1.5
1.5
—
—
—
0
0
73
653
1.14
0.42
2.2
3.1
1.02
1.02
kg/l
0.43
41
403
5
32
1.56
0.42
1.6
1.3
—
—
—
0
0
23
281
0.80
0.42
1.2
1.2
6.76
7.21
u/ml
0.05
15
219
13
96
1.36
0.41
1.5
1.5
—
—
—
0
0
14
105
1.34
0.40
2.2
1.4
—
—
—
0
0
14
105
1.34
0.40
2.2
1.4
—
—
—
0
0
23
186
1.25
0.40
1.5
1.4
200.86
101.12
u/ml
—
7
52
63
699
0.88
0.39
2.4
2.5
—
—
—
0
0
25
300
0.82
0.39
1.2
1.2
5.18
2.82
u/ml
0.32
17
231
9
66
1.37
0.38
2.1
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
36
1.39
0.38
1.6
1.3
—
—
—
0
0
23
276
0.82
0.36
1.2
1.2
2.67
1.46
u/ml
0.29
14
207
18
143
1.27
0.36
1.3
1.1
—
14.14
—
0
20
6
41
1.46
0.36
2.2
1.5
1.04
2.45
ratio
—
6
22
6
43
1.40
0.35
2.3
1.6
29.55
33.27
mg/l
—
6
37
6
43
1.40
0.35
2.3
1.6
29.08
66.39
mg/l
—
6
37
6
43
1.40
0.35
5.5
5.1
0.33
0.74
index
—
6
43
33
284
1.17
0.33
1.1
1.3
10.04
2.15
u/ml
—
8
95
14
109
1.29
0.33
1.8
2.1
1.06
1.26
g/l
0.60
14
97
67
608
1.12
0.32
6.6
3.9
0.60
0.52
e6/l
0.11
44
321
16
128
1.26
0.31
1.2
1.1
—
2.56
—
0
6
210
2016
1.08
0.30
4.7
4.5
6.29
7.61
mm/h
1.27
200
1898
14
111
1.27
0.29
1.6
1.7
24.18
4.86
u/ml
—
5
31
330
3228
1.10
0.28
17.5
13.6
24.30
25.33
mg/l
0.22
256
2382
13
103
1.27
0.27
1.6
2.4
0.93
0.44
nmol/l
1.92
13
92
289
2940
0.93
0.26
3.7
3.6
—
—
—
0
0
11
86
1.28
0.25
1.5
2.5
—
—
—
0
0
13
105
1.24
0.24
1.5
3.6
—
—
—
0
0
13
105
1.24
0.24
1.5
1.4
139.89
190.04
miu/ml
—
8
49
12
96
1.25
0.24
6.2
4.0
13.58
9.59
%
0.75
12
96
17
200
0.84
0.24
1.5
1.2
—
—
—
0
0
14
168
0.82
0.24
4.4
6.7
—
—
—
0
0
10
78
1.28
0.23
3.2
2.9
131.40
133.10
g/l
—
5
68
5
39
1.28
0.23
1.6
1.3
—
—
—
0
0
117
1221
0.94
0.22
2.0
1.9
—
—
—
0
0
5
41
1.22
0.22
1.2
1.2
89.80
72.34
%
—
5
41
0
10
0.00
0.21
0.0
13.1
—
11.94
—
0
10
0
10
0.00
0.21
0.0
1.1
—
106.10
—
0
10
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
3.2
—
123.30
—
0
10
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
209
2025
1.06
0.20
12.1
13.2
3.79
3.66
e9/l
0.33
175
1675
0
14
0.00
0.20
0.0
2.7
—
54.07
—
0
14
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
14
117
1.20
0.20
1.6
1.6
—
—
—
0
0
6
49
1.22
0.20
1.8
1.9
—
—
—
0
0
202
2065
0.95
0.19
4.0
4.2
37.39
39.85
u/l
0.31
194
1982
7
58
1.21
0.18
1.4
1.4
—
193.33
—
0
9
33
359
0.91
0.17
1.5
1.6
3.66
3.84
ratio
0.28
23
258
5
68
0.73
0.17
1.4
1.1
—
—
—
0
0
8
71
1.12
0.16
1.6
1.7
—
—
—
0
0
15
171
0.87
0.15
2.9
2.1
—
—
—
0
0
9
78
1.15
0.15
1.1
1.3
—
—
—
0
0
8
95
0.84
0.14
1.5
1.2
—
—
—
0
0
10
84
1.19
0.13
1.3
1.2
—
134.97
—
0
21
16
179
0.89
0.13
1.2
1.1
2.48
8.74
u/ml
2.41
11
129
51
481
1.06
0.12
3.0
2.1
—
—
—
0
0
15
168
0.89
0.12
3.0
2.2
83.44
101.04
au/ml
—
9
70
12
104
1.15
0.12
1.2
1.2
—
—
—
0
0
20
181
1.11
0.11
1.5
1.4
—
—
—
0
0
77
738
1.05
0.11
3.3
3.4
19.04
52.96
ng/l
1.20
53
475
76
730
1.05
0.10
3.0
3.3
56.89
58.92
u/l
0.15
71
694
65
622
1.05
0.10
4.7
3.6
0.00
0.01
estimate
0.74
20
212
5
44
1.13
0.10
5.8
4.0
28.63
20.58
ug/l
—
5
44
5
48
1.04
0.09
1.4
1.2
259.80
212.40
pmol/l
—
5
48
110
1123
0.97
0.09
1.8
1.7
6.61
1.91
u/ml
0.47
21
220
25
266
0.93
0.08
2.4
2.6
—
—
—
0
0
21
225
0.93
0.08
2.8
2.0
165.71
176.28
u/ml
0.10
14
100
5
63
0.79
0.08
1.0
1.0
145.00
165.78
g/l
—
5
63
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
10
88
1.14
0.07
6.4
4.1
21.80
26.74
%
—
10
88
8
74
1.08
0.07
1.8
2.3
—
—
—
0
0
69
667
1.04
0.07
5.3
2.9
0.00
0.00
estimate
-0.00
20
187
41
392
1.05
0.06
3.0
2.0
—
—
—
0
0
19
202
0.93
0.06
3.4
1.6
—
—
—
0
0
22
208
1.06
0.04
1.6
1.8
—
—
—
0
0
32
331
0.96
0.04
1.0
1.1
—
—
—
0
0
65
662
0.97
0.04
2.2
2.4
—
—
—
0
0
40
387
1.03
0.03
3.2
2.1
—
—
—
0
0
22
210
1.05
0.03
2.3
2.9
—
—
—
0
0
21
218
0.96
0.03
1.4
1.2
—
4.21
—
0
12
32
327
0.97
0.02
1.2
1.2
63.84
15.93
iu/ml
—
10
72
18
173
1.04
0.01
1.1
1.1
0.05
1.15
u/ml
—
7
104
16
159
1.00
0.00
1.1
1.1
0.96
0.91
g/l
0.33
16
159
24
239
1.00
0.00
2.4
2.5
—
—
—
0
0
16
157
1.02
0.00
1.1
1.1
1.35
1.40
g/l
0.42
16
157
21
207
1.01
0.00
1.4
1.3
—
—
—
0
0
29
286
1.01
0.00
1.3
1.4
3.53
3.57
mmol/l
0.05
18
183
18
184
0.97
0.00
4.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
43.00
—
0
5
0
5
0.00
-0.00
0.0
22.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
64
0.93
-0.00
1.8
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
56.22
—
0
5
7
72
0.97
-0.00
1.0
1.7
—
—
—
0
0
6
66
0.90
-0.00
1.3
1.3
—
31.54
—
0
8
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
57.18
—
0
9
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
335.80
—
0
5
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_UNDES_TESTICLE – Undescended testicle
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).